Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, fentanyl, and magnesium sulphate as adjuvants to hyperbaric bupivacaine for spinal anesthesia in knee arthroscopy
PACTR202501636694793Phase 3Recruiting
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine, fentanyl, magnesium sulfate and bupivacaine in pain. Primary endpoints: Onset of analgesia, Duration of analgesia and 2 more. Started Nov 2024; status: recruiting.
02
Drugs
dexmedetomidinefentanylmagnesium sulfatebupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on PACTR202501636694793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501636694793.